BRISBANE, Australia — A drug described as potential new immunotherapy for COVID-19 will enter a clinical trial in the U.S. led by former Australian of the Year Professor Ian Frazer. Developed by Brisbane and Seattle-based company Implicit Bioscience, the drug, IC14, will this week be tested in Covid-19 patients in 10-15 hospitals across the U.S. The new drug, for which Frazer […]

The post Australian Researcher-led New Drug Candidate To Fight Covid-19 Begins Trial first appeared on The Florida Star | The Georgia Star.